1. Home
  2. BRDG vs CERS Comparison

BRDG vs CERS Comparison

Compare BRDG & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRDG
  • CERS
  • Stock Information
  • Founded
  • BRDG 2009
  • CERS 1991
  • Country
  • BRDG United States
  • CERS United States
  • Employees
  • BRDG N/A
  • CERS N/A
  • Industry
  • BRDG Investment Managers
  • CERS EDP Services
  • Sector
  • BRDG Finance
  • CERS Technology
  • Exchange
  • BRDG Nasdaq
  • CERS Nasdaq
  • Market Cap
  • BRDG 430.9M
  • CERS 347.3M
  • IPO Year
  • BRDG 2021
  • CERS 1997
  • Fundamental
  • Price
  • BRDG $9.66
  • CERS $1.38
  • Analyst Decision
  • BRDG Hold
  • CERS Strong Buy
  • Analyst Count
  • BRDG 5
  • CERS 2
  • Target Price
  • BRDG $11.40
  • CERS $3.50
  • AVG Volume (30 Days)
  • BRDG 472.3K
  • CERS 1.5M
  • Earning Date
  • BRDG 05-07-2025
  • CERS 05-01-2025
  • Dividend Yield
  • BRDG 4.79%
  • CERS N/A
  • EPS Growth
  • BRDG N/A
  • CERS N/A
  • EPS
  • BRDG 0.13
  • CERS N/A
  • Revenue
  • BRDG $419,220,000.00
  • CERS $180,270,000.00
  • Revenue This Year
  • BRDG N/A
  • CERS $25.22
  • Revenue Next Year
  • BRDG $26.25
  • CERS $10.08
  • P/E Ratio
  • BRDG $73.64
  • CERS N/A
  • Revenue Growth
  • BRDG 61.35
  • CERS 15.29
  • 52 Week Low
  • BRDG $6.31
  • CERS $1.34
  • 52 Week High
  • BRDG $11.69
  • CERS $2.54
  • Technical
  • Relative Strength Index (RSI)
  • BRDG 51.26
  • CERS 35.86
  • Support Level
  • BRDG $9.23
  • CERS $1.40
  • Resistance Level
  • BRDG $10.52
  • CERS $1.58
  • Average True Range (ATR)
  • BRDG 0.33
  • CERS 0.08
  • MACD
  • BRDG -0.08
  • CERS -0.00
  • Stochastic Oscillator
  • BRDG 37.41
  • CERS 16.00

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: